Diligence memo · auto-generated · as of July 2, 2026
Smart Health Diagnostics Co
Smart Health Diagnostics Co looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Smart Health Diagnostics Co operates in Biotechnology, based in IRVINE.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Smart Health Diagnostics Co has raised $17M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $16M on 2023-03-24.
Most recent recorded round closed around 2024-11-15.
Valuation (modeled)modeled
Provath models Smart Health Diagnostics Co at approximately $1.8M (range $600K–$3.0M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.01× the median modeled value of Series B Biotechnology companies in 2022–2024 (197 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 4 months.
Last raise 20 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 4.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 66% of Biotechnology peers (4293 compared).
Modeled value ranks above 5% of those peers.
Closest niche peers: Mt McKinley Medical Holding Corp USA, YAP Therapeutics Inc, Pinteon Therapeutics, Inc., OncXerna Therapeutics, Ltd., EpiBiologics, Inc..
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.